CR Group L.P. - 09 May 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG Partners III - Parallel Fund B (Cayman) LP
Issuer symbol
TTOO
Transactions as of
09 May 2024
Net transactions value
$0
Form type
4
Filing time
13 May 2024, 18:19:50 UTC
Previous filing
07 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Conversion of derivative security +1,716,048 +60% 4,595,977 09 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P. F1, F2
transaction TTOO Common Stock Conversion of derivative security +108,752 +2.4% 4,704,729 09 May 2024 By CRG Partners III - Parallel Fund B (Cayman) L.P. F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Series A Preferred Stock Conversion of derivative security $0 -17,160 -100% $0.000000* 0 09 May 2024 Common Stock 1,716,048 By CRG Partners III - Parallel Fund B (Cayman) L.P. F1, F2
transaction TTOO Series B Preferred Stock Conversion of derivative security $0 -10,875 -100% $0.000000* 0 09 May 2024 Common Stock 108,752 By CRG Partners III - Parallel Fund B (Cayman) L.P. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock converted into 100 shares of Common Stock for no additional consideration and has no expiration date.
F2 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
F3 Each share of Series B Preferred Stock converted into 10 shares of Common Stock for no additional consideration and has no expiration date.